News Release

Study finds immune cell ‘memories’ can increase the risk for blood clots long after inflammation

Peer-Reviewed Publication

RCSI

New research from RCSI University of Medicine and Health Sciences has found that white blood cells which ‘remember’ past inflammation events are quick to overreact, raising the risk of blood clots. 

People living with inflammatory conditions, such as inflammatory bowel disease, blood cancers and sickle cell anaemia, can have a higher risk of blood clots. The new study, published in the high-impact journal Science Advances, explores how episodes of inflammation in such diseases can result in the production of white blood cells called myeloid cells that have increased blood-clotting activity, which persists long after the inflammation took place. 

Immune memories are important, according to researcher Dr Aisling Rehill, Senior Postdoctoral Fellow at the Irish Centre for Vascular Biology, RCSI. “Certain immune cells can ‘remember’ past encounters with inflammation or infection, a concept known as trained immunity. This memory allows them to respond more aggressively to future threats,” says Dr Rehill. 

But this ‘shortened fuse’ could have consequences that are not desirable and actually contribute to disease, she adds. 

“Our study found that this heightened response can have unintended consequences. When these myeloid cells in the immune system have been trained by prior exposure to specific inflammatory agents, they also become more likely to promote blood clotting. Similarly, mice trained by exposure to specific inflammatory agents experience changes in their bone marrow that mean they produce new immune cells with a lower threshold to start blood clotting weeks after the original exposure.” 

The research, which was carried out by experts at RCSI, FutureNeuro, Trinity College Dublin and Children’s Health Ireland, could help to explain why people living with inflammatory disease can have a relatively high risk of blood clots and the complications they bring, according to lead researcher on the study Professor Roger Preston. 

“If this was translated to humans, the study suggests that while trained immunity can boost the body’s defence against infections, it may also contribute to the risk of blood clot-related complications in individuals with inflammatory disease,” says Professor Preston, who is an Associate Professor at RCSI School of Pharmacy and Biomolecular Sciences.   

“The findings suggest that periods of inflammation during disease could cause the generation of immune cells with increased clotting activity long after the original inflammatory event has taken place.” 

The authors also suggest that the insights from the study could form the basis for targeted treatments to help prevent or manage conditions where the immune system and clotting system are overly active.

The research was funded by Research Ireland, the Health Research Board and Children’s Health Foundation and the paper ‘Trained hypercoagulability in myeloid cells’ is published in the journal Science Advances

ENDS 

For further information:  

Laura Anderson, Communications Officer, RCSI 

087 199 0399/ lauraanderson@rcsi.ie 
 

About RCSI University of Medicine and Health Sciences  

RCSI University of Medicine and Health Sciences is ranked fifth in the world for its contribution to UN Sustainable Development Goal 3, Good Health and Well-being, in the Times Higher Education (THE) University Impact Rankings 2024.    

Founded in 1784 as the Royal College of Surgeons in Ireland with responsibility for training surgeons in Ireland, today RCSI is an innovative, not-for-profit, international university exclusively focused on driving improvements in human health worldwide through education, research and engagement.   

RCSI is among the top 300 universities worldwide in the World University Rankings (2025) and has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.    

In 2026, RCSI will open a new public engagement space, dedicated to health and well-being, at 118 St Stephen’s Green in Dublin city centre. The space is designed to engage the public in dialogue about living longer, healthier and happier lives through dynamic events and exhibitions. Our aim is to bridge the gap between health sciences research, professional expertise, and public understanding, empowering people to make informed decisions about their health.  

Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.